ArticleJournal of neuro-oncology2020

RIPK3 is a novel prognostic marker for lower grade glioma and further enriches IDH mutational status subgrouping.

Guilherme Afonso Vergara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.